Patient outcomes in dose reduction or discontinuation of long-term opioid therapy: A systematic review

Joseph W. Frank, Travis I. Lovejoy, William C. Becker, Benjamin J. Morasco, Christopher J. Koenig, Lilian Hoffecker, Hannah R. Dischinger, Steven K. Dobscha, Erin E. Krebs

Research output: Research - peer-reviewReview article

  • 3 Citations

Abstract

Background: Expert guidelines recommend reducing or discontinuing long-term opioid therapy (LTOT) when risks outweigh benefits, but evidence on the effect of dose reduction on patient outcomes has not been systematically reviewed. Purpose: To synthesize studies of the effectiveness of strategies to reduce or discontinue LTOT and patient outcomes after dose reduction among adults prescribed LTOT for chronic pain. Data Sources: MEDLINE, EMBASE, PsycINFO, CINAHL, and the Cochrane Library from inception through April 2017; reference lists; and expert contacts. Study Selection: Original research published in English that addressed dose reduction or discontinuation of LTOT for chronic pain. Data Extraction: Two independent reviewers extracted data and assessed study quality using the U.S. Preventive Services Task Force quality rating criteria. All authors assessed evidence quality using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) system. Prespecified patient outcomes were pain severity, function, quality of life, opioid withdrawal symptoms, substance use, and adverse events. Data Synthesis: Sixty-seven studies (11 randomized trials and 56 observational studies) examining 8 intervention categories, including interdisciplinary pain programs, buprenorphine-assisted dose reduction, and behavioral interventions, were found. Study quality was good for 3 studies, fair for 13 studies, and poor for 51 studies. Many studies reported dose reduction, but rates of opioid discontinuation ranged widely across interventions and the overall quality of evidence was very low. Among 40 studies examining patient outcomes after dose reduction (very low overall quality of evidence), improvement was reported in pain severity (8 of 8 fair-quality studies), function (5 of 5 fair-quality studies), and quality of life (3 of 3 fair-quality studies). Limitation: Heterogeneous interventions and outcome measures; poor-quality studies with uncontrolled designs. Conclusion: Very low quality evidence suggests that several types of interventions may be effective to reduce or discontinue LTOT and that pain, function, and quality of life may improve with opioid dose reduction.

LanguageEnglish (US)
Pages181-191
Number of pages11
JournalAnnals of Internal Medicine
Volume167
Issue number3
DOIs
StatePublished - Aug 1 2017
Externally publishedYes

Fingerprint

Opioid Analgesics
Therapeutics
Pain
Quality of Life
Chronic Pain
Buprenorphine
Substance Withdrawal Syndrome
Information Storage and Retrieval
Advisory Committees
Quality Improvement
MEDLINE
Libraries
Observational Studies
Outcome Assessment (Health Care)
Guidelines
Research

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Frank, J. W., Lovejoy, T. I., Becker, W. C., Morasco, B. J., Koenig, C. J., Hoffecker, L., ... Krebs, E. E. (2017). Patient outcomes in dose reduction or discontinuation of long-term opioid therapy: A systematic review. Annals of Internal Medicine, 167(3), 181-191. DOI: 10.7326/M17-0598

Patient outcomes in dose reduction or discontinuation of long-term opioid therapy : A systematic review. / Frank, Joseph W.; Lovejoy, Travis I.; Becker, William C.; Morasco, Benjamin J.; Koenig, Christopher J.; Hoffecker, Lilian; Dischinger, Hannah R.; Dobscha, Steven K.; Krebs, Erin E.

In: Annals of Internal Medicine, Vol. 167, No. 3, 01.08.2017, p. 181-191.

Research output: Research - peer-reviewReview article

Frank, JW, Lovejoy, TI, Becker, WC, Morasco, BJ, Koenig, CJ, Hoffecker, L, Dischinger, HR, Dobscha, SK & Krebs, EE 2017, 'Patient outcomes in dose reduction or discontinuation of long-term opioid therapy: A systematic review' Annals of Internal Medicine, vol 167, no. 3, pp. 181-191. DOI: 10.7326/M17-0598
Frank JW, Lovejoy TI, Becker WC, Morasco BJ, Koenig CJ, Hoffecker L et al. Patient outcomes in dose reduction or discontinuation of long-term opioid therapy: A systematic review. Annals of Internal Medicine. 2017 Aug 1;167(3):181-191. Available from, DOI: 10.7326/M17-0598
Frank, Joseph W. ; Lovejoy, Travis I. ; Becker, William C. ; Morasco, Benjamin J. ; Koenig, Christopher J. ; Hoffecker, Lilian ; Dischinger, Hannah R. ; Dobscha, Steven K. ; Krebs, Erin E./ Patient outcomes in dose reduction or discontinuation of long-term opioid therapy : A systematic review. In: Annals of Internal Medicine. 2017 ; Vol. 167, No. 3. pp. 181-191
@article{18b9f418ad5545e89d8ae3099c4f95ff,
title = "Patient outcomes in dose reduction or discontinuation of long-term opioid therapy: A systematic review",
abstract = "Background: Expert guidelines recommend reducing or discontinuing long-term opioid therapy (LTOT) when risks outweigh benefits, but evidence on the effect of dose reduction on patient outcomes has not been systematically reviewed. Purpose: To synthesize studies of the effectiveness of strategies to reduce or discontinue LTOT and patient outcomes after dose reduction among adults prescribed LTOT for chronic pain. Data Sources: MEDLINE, EMBASE, PsycINFO, CINAHL, and the Cochrane Library from inception through April 2017; reference lists; and expert contacts. Study Selection: Original research published in English that addressed dose reduction or discontinuation of LTOT for chronic pain. Data Extraction: Two independent reviewers extracted data and assessed study quality using the U.S. Preventive Services Task Force quality rating criteria. All authors assessed evidence quality using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) system. Prespecified patient outcomes were pain severity, function, quality of life, opioid withdrawal symptoms, substance use, and adverse events. Data Synthesis: Sixty-seven studies (11 randomized trials and 56 observational studies) examining 8 intervention categories, including interdisciplinary pain programs, buprenorphine-assisted dose reduction, and behavioral interventions, were found. Study quality was good for 3 studies, fair for 13 studies, and poor for 51 studies. Many studies reported dose reduction, but rates of opioid discontinuation ranged widely across interventions and the overall quality of evidence was very low. Among 40 studies examining patient outcomes after dose reduction (very low overall quality of evidence), improvement was reported in pain severity (8 of 8 fair-quality studies), function (5 of 5 fair-quality studies), and quality of life (3 of 3 fair-quality studies). Limitation: Heterogeneous interventions and outcome measures; poor-quality studies with uncontrolled designs. Conclusion: Very low quality evidence suggests that several types of interventions may be effective to reduce or discontinue LTOT and that pain, function, and quality of life may improve with opioid dose reduction.",
author = "Frank, {Joseph W.} and Lovejoy, {Travis I.} and Becker, {William C.} and Morasco, {Benjamin J.} and Koenig, {Christopher J.} and Lilian Hoffecker and Dischinger, {Hannah R.} and Dobscha, {Steven K.} and Krebs, {Erin E.}",
year = "2017",
month = "8",
doi = "10.7326/M17-0598",
volume = "167",
pages = "181--191",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "3",

}

TY - JOUR

T1 - Patient outcomes in dose reduction or discontinuation of long-term opioid therapy

T2 - Annals of Internal Medicine

AU - Frank,Joseph W.

AU - Lovejoy,Travis I.

AU - Becker,William C.

AU - Morasco,Benjamin J.

AU - Koenig,Christopher J.

AU - Hoffecker,Lilian

AU - Dischinger,Hannah R.

AU - Dobscha,Steven K.

AU - Krebs,Erin E.

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Background: Expert guidelines recommend reducing or discontinuing long-term opioid therapy (LTOT) when risks outweigh benefits, but evidence on the effect of dose reduction on patient outcomes has not been systematically reviewed. Purpose: To synthesize studies of the effectiveness of strategies to reduce or discontinue LTOT and patient outcomes after dose reduction among adults prescribed LTOT for chronic pain. Data Sources: MEDLINE, EMBASE, PsycINFO, CINAHL, and the Cochrane Library from inception through April 2017; reference lists; and expert contacts. Study Selection: Original research published in English that addressed dose reduction or discontinuation of LTOT for chronic pain. Data Extraction: Two independent reviewers extracted data and assessed study quality using the U.S. Preventive Services Task Force quality rating criteria. All authors assessed evidence quality using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) system. Prespecified patient outcomes were pain severity, function, quality of life, opioid withdrawal symptoms, substance use, and adverse events. Data Synthesis: Sixty-seven studies (11 randomized trials and 56 observational studies) examining 8 intervention categories, including interdisciplinary pain programs, buprenorphine-assisted dose reduction, and behavioral interventions, were found. Study quality was good for 3 studies, fair for 13 studies, and poor for 51 studies. Many studies reported dose reduction, but rates of opioid discontinuation ranged widely across interventions and the overall quality of evidence was very low. Among 40 studies examining patient outcomes after dose reduction (very low overall quality of evidence), improvement was reported in pain severity (8 of 8 fair-quality studies), function (5 of 5 fair-quality studies), and quality of life (3 of 3 fair-quality studies). Limitation: Heterogeneous interventions and outcome measures; poor-quality studies with uncontrolled designs. Conclusion: Very low quality evidence suggests that several types of interventions may be effective to reduce or discontinue LTOT and that pain, function, and quality of life may improve with opioid dose reduction.

AB - Background: Expert guidelines recommend reducing or discontinuing long-term opioid therapy (LTOT) when risks outweigh benefits, but evidence on the effect of dose reduction on patient outcomes has not been systematically reviewed. Purpose: To synthesize studies of the effectiveness of strategies to reduce or discontinue LTOT and patient outcomes after dose reduction among adults prescribed LTOT for chronic pain. Data Sources: MEDLINE, EMBASE, PsycINFO, CINAHL, and the Cochrane Library from inception through April 2017; reference lists; and expert contacts. Study Selection: Original research published in English that addressed dose reduction or discontinuation of LTOT for chronic pain. Data Extraction: Two independent reviewers extracted data and assessed study quality using the U.S. Preventive Services Task Force quality rating criteria. All authors assessed evidence quality using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) system. Prespecified patient outcomes were pain severity, function, quality of life, opioid withdrawal symptoms, substance use, and adverse events. Data Synthesis: Sixty-seven studies (11 randomized trials and 56 observational studies) examining 8 intervention categories, including interdisciplinary pain programs, buprenorphine-assisted dose reduction, and behavioral interventions, were found. Study quality was good for 3 studies, fair for 13 studies, and poor for 51 studies. Many studies reported dose reduction, but rates of opioid discontinuation ranged widely across interventions and the overall quality of evidence was very low. Among 40 studies examining patient outcomes after dose reduction (very low overall quality of evidence), improvement was reported in pain severity (8 of 8 fair-quality studies), function (5 of 5 fair-quality studies), and quality of life (3 of 3 fair-quality studies). Limitation: Heterogeneous interventions and outcome measures; poor-quality studies with uncontrolled designs. Conclusion: Very low quality evidence suggests that several types of interventions may be effective to reduce or discontinue LTOT and that pain, function, and quality of life may improve with opioid dose reduction.

UR - http://www.scopus.com/inward/record.url?scp=85026664978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026664978&partnerID=8YFLogxK

U2 - 10.7326/M17-0598

DO - 10.7326/M17-0598

M3 - Review article

VL - 167

SP - 181

EP - 191

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 3

ER -